NatureWise Biotech & Medicals Corporation (4732.TWO)

26.90 +0.35 (+1.32%) At close: 01:09PM CST

NatureWise Biotech & Medicals Corporation

No. 36, Bade Road
6F Section 3
Taipei 105
Taiwan
886 2 2570 6300
https://www.naturewise.com.tw

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Zhong Yang Huang	Chairman & Acting President	N/A	N/A	N/A
Jun Kai Chen	Chief Financial Officer and Assistant Vice President	N/A	N/A	N/A
Xing Ling Cai	Marketing Manager	N/A	N/A	N/A
Nian Ci Hong	Treasurer & Audit Office Manager	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.

Description

NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; PPL Taiwan green propolis; and NBM-BMX, an oral softgel capsule to treat cancer. The company was founded in 2000 and is based in Taipei, Taiwan.

Corporate governance

NatureWise Biotech & Medicals Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.